Moreover, we generated and delivered lentivirus‐bearing shRNAs targeting RTN4IP1 or scramble into ESCC patient‐derived xenograft (PDX) to achieve in vivo knockdown of RNT4IP1. Here, RTN4IP1 is linked to esophageal squamous cell carcinoma.